To examine the efficacy of anti-Gal-9 therapy in ATM-silenced tumors, we first established an ATM knockdown (KD) cancer cell line by transducing the murine CT26 colon cancer cells with lentiviruses encoding shRNA for ATM. The gene discussed is LGALS9; the disease is colonic neoplasm.